Kerem S. Okutur
Bahcelievler, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.
Journal: Immunotherapy
Published: September 02, 2026
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Journal: Future oncology (London, England)
Published: October 17, 2025
Multilocus inherited neoplasia allele syndrome (MINAS) in a Turkish cohort: molecular insights and clinical relevance for precision oncology.
Journal: Frontiers in pharmacology
Published: July 24, 2025
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Journal: Scientific reports
Published: March 19, 2025
Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study.
Journal: Medicina (Kaunas, Lithuania)
Published: February 15, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study.
Journal: Molecular and clinical oncology
Published: December 17, 2024
Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020-2022).
Journal: Current medical research and opinion
Published: June 10, 2023
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Journal: BMC cancer
Published: February 28, 2023
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Journal: BMC cancer
Published: September 15, 2022
Last Updated: 09/26/2026